Tag: Polymorph

Salt and Polymorph Failures in Pharma: Common Causes and Investigation Approach Understanding Salt and Polymorph Failures in Pharmaceutical Development The process of API (Active Pharmaceutical Ingredient) development is a multi-faceted endeavor that often includes the selection of appropriate salts and…

Solid Form Selection in Pharma: Practical Examples from API to Finished Product Understanding Solid Form Selection in the Pharmaceutical Industry The selection of the appropriate solid form of an Active Pharmaceutical Ingredient (API) is critical in pharmaceutical development. This process…

Polymorph Control Strategy in API Development and Regulatory Filings Understanding Polymorph Control Strategies in API Development and Regulatory Submissions In the pharmaceutical industry, the development of Active Pharmaceutical Ingredients (APIs) is a complex process that requires meticulous attention to various…

Why Solid Form Selection Matters in Tech Transfer and Commercial Manufacturing The Significance of Solid Form Selection in Tech Transfer and Commercial Manufacturing In the pharmaceutical industry, the selection of the appropriate solid form—be it salt forms, polymorphs, or amorphous…

What Is Solid Form Selection in Pharma and Why Is It Critical? Understanding Solid Form Selection in Pharmaceuticals and Its Importance Solid form selection is a crucial aspect of pharmaceutical development that significantly influences the efficacy, stability, and manufacturability of…

How Salt Selection Affects Bioavailability, Stability, and Formulation Performance The Impact of Salt, Polymorph, and Solid Form Selection on Drug Performance In the realm of pharmaceutical development, the selection of the appropriate salt, polymorph, and solid form of an Active…

Polymorphism in Pharma: Risks in API Manufacturing, Storage, and Filing Understanding Polymorphism in Pharmaceuticals: Implications for API Manufacturing and Storage Polymorphism is a significant phenomenon in the pharmaceutical industry, especially in the context of active pharmaceutical ingredient (API) development and…

Salt Screening and Polymorph Screening in Pharma: What Is the Difference? Understanding the Differences Between Salt Selection and Polymorph Screening in Pharma In the highly regulated and complex world of pharmaceuticals, the selection of the appropriate solid form of an…

Interview Questions on Salt Form and Polymorph Selection in Pharma Key Considerations for Salt, Polymorph, and Solid Form Selection in Pharmaceutical Development The selection of salts, polymorphs, and solid forms is a critical aspect of drug development that significantly influences…

Solid Form Changes in API Manufacturing: What QA, QC, and R&D Should Watch Key Considerations for Salt, Polymorph, and Solid Form Selection in API Manufacturing In the realm of pharmaceutical development, the selection of salt, polymorph, and solid forms is…